461 related articles for article (PubMed ID: 30653334)
1. An Australian local diagnostic reference level for paediatric whole-body
Alkhybari EM; McEntee MF; Willowson KP; Brennan PC; Kitsos T; Kench PL
Br J Radiol; 2019 Apr; 92(1096):20180879. PubMed ID: 30653334
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic reference levels for
Alkhybari EM; McEntee MF; Brennan PC; Willowson KP; Kench PL
J Med Imaging Radiat Oncol; 2019 Jun; 63(3):291-299. PubMed ID: 30770654
[TBL] [Abstract][Full Text] [Related]
3. National and local diagnostic reference levels for adult
Alhorani Q; Alkhybari E; Rawashdeh M; Sabarudin A; Latiff RA; Al-Ibraheem A; Mohamad M
J Radiol Prot; 2024 Mar; 44(1):. PubMed ID: 38387102
[TBL] [Abstract][Full Text] [Related]
4. Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in children: a proposal to update the EANM Paediatric Dosage Card.
Tran-Gia J; Eberlein U; Lassmann M; Mauz-Körholz C; Körholz D; Zuccetta P; Bar-Sever Z; Rosner U; Georgi TW; Sabri O; Kluge R; Piccardo A; Kurch L
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):405-411. PubMed ID: 37728668
[TBL] [Abstract][Full Text] [Related]
5. Defining optimal tracer activities in pediatric oncologic whole-body
Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF; Schäfer JF
Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2283-2289. PubMed ID: 27565153
[TBL] [Abstract][Full Text] [Related]
6. Preliminary study on diagnostic reference levels of whole-body PET-CT examinations in Jiangsu Province, China.
Wang Q; Wang J; Cao X; Li Q; Xie S; Sang J; Zhang Y; Xue C; Fu Q
Radiat Prot Dosimetry; 2023 Aug; 199(13):1416-1422. PubMed ID: 37452483
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic reference levels of paediatric computed tomography examinations performed at a dedicated Australian paediatric hospital.
Bibbo G; Brown S; Linke R
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):475-84. PubMed ID: 27378436
[TBL] [Abstract][Full Text] [Related]
8. Whole-body MRI versus an [
Spijkers S; Littooij AS; Kwee TC; Tolboom N; Beishuizen A; Bruin MCA; Enríquez G; Sábado C; Miller E; Granata C; de Lange C; Verzegnassi F; de Keizer B; Nievelstein RAJ
Eur Radiol; 2021 Dec; 31(12):8925-8936. PubMed ID: 34021390
[TBL] [Abstract][Full Text] [Related]
9. The effect of modern PET technology and techniques on the EANM paediatric dosage card.
Dickson J; Eberlein U; Lassmann M
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1964-1969. PubMed ID: 34910233
[TBL] [Abstract][Full Text] [Related]
10. A new upper limit for effective dose in patient administered with 18F-FDG for PET/CT whole-body imaging with diagnostic CT parameters.
Velo P; Ismail MI; Mohandas KK; Kasilingam L
J Med Imaging Radiat Sci; 2023 Mar; 54(1):43-50. PubMed ID: 36402716
[TBL] [Abstract][Full Text] [Related]
11. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
Albano D; Patti C; Lagalla R; Midiri M; Galia M
J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
[TBL] [Abstract][Full Text] [Related]
12. Derivation of Australian diagnostic reference levels for paediatric multi detector computed tomography.
Hayton A; Wallace A
Australas Phys Eng Sci Med; 2016 Sep; 39(3):615-26. PubMed ID: 27350262
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of Computed Tomography Exposure Dose for Whole-body
Maeda Y; Taniguchi Y; Takauchi K; Kageyama S; Kangai Y; Kenda S
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2019; 75(1):62-67. PubMed ID: 30662034
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
16. Significantly Low Effective Dose from 18FDG PET/CT Scans Using Dose Reducing Strategies: "Lesser is Better".
Zaman MU; Fatima N; Zaman A; Zaman U; Tahseen R
Asian Pac J Cancer Prev; 2016; 17(7):3465-8. PubMed ID: 27509993
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of
Basha MAA; Hamed MAG; Refaat R; AlAzzazy MZ; Bessar MA; Mohamed EM; Ahmed AF; Tantawy HF; Altaher KM; Obaya AA; Afifi AHM
Jpn J Radiol; 2018 Jun; 36(6):382-393. PubMed ID: 29671193
[TBL] [Abstract][Full Text] [Related]
18. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including
Latifoltojar A; Punwani S; Lopes A; Humphries PD; Klusmann M; Menezes LJ; Daw S; Shankar A; Neriman D; Fitzke H; Clifton-Hadley L; Smith P; Taylor SA
Eur Radiol; 2019 Jan; 29(1):202-212. PubMed ID: 29948084
[TBL] [Abstract][Full Text] [Related]
19. Quantification of DNA damage in patients undergoing non-contrast and contrast enhanced whole body PET/CT investigations using comet assay and micronucleus assay.
Nautiyal A; Mondal T; Mukherjee A; Mitra D; Kaushik A; Goel HC; Goel A; Dey SK
Int J Radiat Biol; 2019 Jun; 95(6):710-719. PubMed ID: 30707050
[No Abstract] [Full Text] [Related]
20. A retrospective evaluation of radiation dose associated with low dose FDG protocols in whole-body PET/CT.
Willowson KP; Bailey EA; Bailey DL
Australas Phys Eng Sci Med; 2012 Mar; 35(1):49-53. PubMed ID: 22160927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
